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The organized accumulation of lymphocytes in 
lymphoid organs serves to optimize both ho-
meostatic immune surveillance and chronic   
responses to pathogenic stimuli (Cupedo and 
Mebius,  2005).  During  embryonic  develop-
ment,  circulating  hemopoietic  cells  gather  at 
predestined sites throughout the body, where 
they are subsequently arranged in T and B cell–
specific areas, which is characteristic of second-
ary lymphoid organs (SLOs). In contrast, the 
body seems to harbor a limited second set of   
selected sites that support neoformation of or-
ganized lymphoid aggregates in adult life. How-
ever, these are only revealed at times of local 
chronic  inflammation  when  so-called  tertiary 
lymphoid organs (TLOs) appear. As such, TLO 
was found in the pancreas of autoimmune dia-
betic mice (Kendall et al., 2007), around blood 
vessels in chronic allograft rejection (Nasr et al., 
2007) and atherosclerosis (Gräbner et al., 2009), 
and in the brain in experimental allergic en-
cephalitis (Magliozzi et al., 2004). In humans, 
TLO has been observed in the joint and lung of 
rheumatoid arthritis (Rangel-Moreno et al., 2006), 
around the airways of COPD patients (Hogg   
et al., 2004), and in the thyroid (Marinkovic et al., 
2006). Certain infectious diseases are also ac-
companied by formation of TLO. Influenza 
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Tertiary lymphoid organs (TLOs) are organized aggregates of B and T cells formed in post-
embryonic life in response to chronic immune responses to infectious agents or self-anti-
gens. Although CD11c+ dendritic cells (DCs) are consistently found in regions of TLO, their 
contribution to TLO organization has not been studied in detail. We found that CD11chi DCs 
are essential for the maintenance of inducible bronchus-associated lymphoid tissue (iBALT), 
a form of TLO induced in the lungs after influenza virus infection. Elimination of DCs after 
the virus had been cleared from the lung resulted in iBALT disintegration and reduction in 
germinal center (GC) reactions, which led to significantly reduced numbers of class-
switched plasma cells in the lung and bone marrow and reduction in protective antiviral 
serum immunoglobulins. Mechanistically, DCs isolated from the lungs of mice with iBALT no 
longer presented viral antigens to T cells but were a source of lymphotoxin (LT)  and 
homeostatic chemokines (CXCL-12 and -13 and CCL-19 and -21) known to contribute to 
TLO organization. Like depletion of DCs, blockade of LT receptor signaling after virus 
clearance led to disintegration of iBALT and GC reactions. Together, our data reveal a 
previously unappreciated function of lung DCs in iBALT homeostasis and humoral immunity 
to influenza virus.
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area containing some CD4 T cells, with a close-by T cell area 
containing DCs and CD4 and CD8 T cells. The B cell area 
contained  follicular  DC  (FDC)–M2+  FDCs  and  PNAD+ 
high endothelial venules in the T cell area (not depicted; 
Rangel-Moreno et al., 2007). Although iBALT was mainly 
present in close proximity to bronchi, it was also seen in the 
lung interstitium.
Lung DCs are necessary for maintenance of iBALT  
after viral clearance
A CD11c diphteria toxin (DT) receptor (DTR) transgenic 
mouse model was used to deplete CD11c+ DCs from the lungs, 
and thus study if these cells were necessary for maintenance of 
iBALT structures (GeurtsvanKessel et al., 2008). Mice received 
DT intratracheally (i.t.) at 17 dpi (Fig. 2 A). CD11b+CD11c+ 
DCs were depleted from the lung (Fig. 2 B) and draining me-
diastinal LN (Fig. S1 A) but not from the spleen or other SLOs 
(not depicted). CD11cinterm plasmacytoid DCs were minimally 
affected by DT treatment (Sapoznikov et al., 2007). Although 
CD11c+ IgM-producing extrafollicular plasmablasts were 
shown to be DT sensitive (Hebel et al., 2006), 24 h after DT 
treatment at 17 dpi, only CD11c+ DCs were significantly 
depleted, whereas CD4+ T cells, CD8+ T cells, B cells, or 
CD138+ plasma cells were not (Fig. S1 D). Staining for F4/80+ 
cells also revealed insensitivity of iBALT macrophages to DT 
(unpublished data), although highly autofluorescent alveolar 
macrophages were depleted (van Rijt et al., 2005). 48 h after 
injection  of  DT,  CD11c+  DCs  had  disappeared  from  the 
iBALT structures, whereas B220+ B cells were still abundantly 
present (Fig. 2 C). Although infected CD11c-DTR Tg mice 
treated with PBS (Fig. 2 C, top left) or nontransgenic mice 
treated with DT (not depicted) had extensive iBALT struc-
tures containing B220+ B cells and CD11c+ cells throughout 
the lung, these structures were significantly reduced after DT 
treatment of CD11c-DTR Tg mice (Fig. 2 C, right). Some 
B220+ B cells were still detected in the lung tissue of DT-
treated mice. Although some cells clustered into discrete re-
gions, the density of B cells was strongly reduced and these 
regions no longer contained CD11c+ cells (Fig. 2 C, insets). 
Histological quantification (Fig. 2 D) revealed a progressive 
decline in the number of iBALT per low-power field that was 
first evident 4 d after DC depletion and was almost complete 
by 1 wk after DC depletion, a time point when CD11b+CD11c+ 
DCs had already returned to the lungs of DT-treated mice 
(Fig. 2 B, bottom). The gradual disappearance of B220+ cells 
and iBALT structures from the lungs, as opposed to the imme-
diate disappearance of CD11c+ DCs, is further proof that 
B220+ B cells were not directly killed by DT treatment but 
were reduced secondary to DC depletion. This conclusion is 
supported by the observation that only 4% of lung B cells ex-
pressed CD11c.
DC depletion after viral clearance affects local humoral 
immune responses
The precise contribution of TLO to adaptive immunity is 
thought to serve local immune responses to microbial-derived 
virus infection of the respiratory tract leads to formation of 
inducible bronchus-associated lymphoid tissue (iBALT) that 
supports T and B cell proliferation and productive immuno-
globulin class switching in germinal centers (GCs; Moyron-
Quiroz et al., 2004, 2006).
Although the embryonic development of SLO requires 
CD3CD4+ lymphoid tissue–inducer cells, these are not a pre-
requisite for TLO induction (Marinkovic et al., 2006; Rangel-
Moreno et al., 2007). Like SLOs, TLOs are formed in a 
highly regulated manner via production of homeostatic che-
mokines (CXCL13 and CCL19/CCL21), partially in response 
to signaling from the heterotrimer lymphotoxin (LT) 12 act-
ing on the LT receptor on stromal lymphoid tissue organizer 
cells (Drayton et al., 2006). The instruction of stromal cells 
leads to formation of specialized high endothelial venules, and 
the organized production of chemokines leads to cellular orga-
nization of T cells and B cells in discrete areas. In all instances 
where TLOs have been described, antigen-presenting DCs 
have been found interspersed with T and B cell area, just   
as they are in SLO (Kratz et al., 1996; Cupedo et al., 2004; 
Moyron-Quiroz et al., 2004; Marinkovic et al., 2006; Tsuji   
et al., 2008). So far, the precise role of DCs in the functional 
organization of TLO has not been studied in great detail. Al-
though DCs are mainly known for their function as antigen-
presenting cells (Banchereau and Steinman, 1998), they are also 
a prominent source of homeostatic and inflammatory chemo-
kines that can attract T and B cells and, thus, may contribute to 
TLO homeostasis (Beaty et al., 2007; GeurtsvanKessel and 
Lambrecht, 2008). In this paper, we have studied the precise 
contribution of DCs in the functional organization of iBALT, 
a specific form of TLO found in the lung after influenza virus 
infection (Moyron-Quiroz et al., 2004; Kocks et al., 2007).
RESULTS AND DISCUSSION
Lung CD11c+ DCs localize to zones of iBALT after clearance 
of influenza virus
Mice were infected intranasally with a nonlethal strain of 
influenza A/HKX-31 (H3N2) that is cleared from the lungs   
at 8 d post infection (dpi; GeurtsvanKessel et al., 2008) and is 
accompanied by formation of iBALT as soon as 10 dpi. At 
various dpi, the presence of CD11c+ DC subsets (CD11b+ and 
CD11b) was determined in dispersed lung cells. In mock-
infected mice, a majority of DCs were CD11b. Up to at least 
24 dpi, the percentage of CD11b+CD11c+ DCs remained 
increased in influenza over mock-infected mice (Fig. 1 A; 
GeurtsvanKessel et al., 2008). CD11c+ DCs were found 
within areas of B220+ B cell aggregates, which were poorly 
delineated at 4 dpi but became progressively more organized 
into discrete lymphoid aggregates at 10 and 24 dpi (Fig. 1 B). 
The number of lung CD11b+CD11c+ DCs (Fig. 1 C) con-
tinued to rise after influenza infection, despite the fact that 
this virus is cleared from the lung at 8 dpi (GeurtsvanKessel   
et al., 2008). The rise in CD11b+ DCs was accompanied by 
a rise in the percentage of lymphocytes recovered in lung cell 
suspensions (Fig. 1 D). At 17 dpi (Fig. 1 E), cell aggregates 
resembled iBALT and were characterized by a B220+ B cell JEM VOL. 206, October 26, 2009  2341
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within B cell regions (Fig. 1 E). Presence of GCs was dem-
onstrated by staining consecutive slides for GL-7 (revealing 
GC B cells) and IgD (revealing mainly mantle B cells) and Ig 
isotypes (Fig. 3 A). In addition to IgD+ B cells, class-switched 
plasma cells secreting IgG and IgA were found at the periph-
ery of the iBALT. Similar conclusions were reached when 
GCs were identified using PNA staining, in which case IgM-
secreting plasmablasts were also found (Fig. S2 A). We next 
addressed whether plasma cells were specific for influenza. 
For this purpose, recombinant nucleoprotein (NP) was used 
antigens or to autoantigens (Aloisi and Pujol-Borrell, 2006). 
Although a role for iBALT in mediating humoral immunity 
to influenza has been proposed, these studies were performed 
in mice lacking SLO through genetic manipulation (Moyron-
Quiroz et al., 2006). The breakdown of iBALT in DC-
depleted mice allowed us to study the functional contribution 
of these local structures to humoral immunity in mice with 
normal SLO. GC B cells undergoing active Ig class switching 
are typically found within TLO, including iBALT (Moyron-
Quiroz et al., 2004). This is supported by the finding of FDCs 
Figure 1.  The development of iBALT structures after influenza virus infection. (A) Flow cytometric analysis of CD11b expression on DCs after 
infection. Numbers in the corners of the plots indicate percentage of MHCII+CD11c+ DCs. (B) Histological slides at 4, 10, and 24 dpi demonstrating B220+ 
and CD11c+ cells. Bars, 100 µm. (C) Histogram indicates absolute numbers of DC11b+ DCs in lung tissue, bars represent mean values of at least five mice/
group, and error bars indicate SEM. **, P < 0.01. (D) B and T cells in lung tissue after infection, depicted as percentage of cells alive. Horizontal bars indi-
cate the mean value. (E) Consecutive histological slides from snap-frozen lung tissue at 17 dpi. B220+ B cell structures could be identified, with CD11c+ 
DCs within the aggregates. Mainly CD4 T cells and some CD8 T cells were present in iBALT and FDCs could be detected. Bars, 100 µm. All results are repre-
sentative of at least three independent experiments with five animals/group.2342 DCS ARE REQUIRED FOR iBALT MAINTENANCE | GeurtsvanKessel et al.
Figure 2.  Depletion of CD11c+ DCs in a CD11c-DTR mouse model abrogates iBALT structures from the lung. (A) At 17 dpi, mice were treated with 
DT i.t. and iBALT was analyzed. (B) At 18 dpi and 24 dpi, depletion was checked in lung tissue. At both time points the majority of conventional DCs (cDCs) 
expressed CD11b. Boxes outline the DC populations, with the numbers indicating mean values of percentage of DCs (of cells alive). (C) At 17 dpi iBALT struc-
tures were quantified by a CD11c-B220 staining in a high-power field (top left). B cell clusters are indicated by arrows. A magnification of iBALT in this field 
is depicted in the inset. At 19, 21, and 24 dpi with and without treatment, B220-CD11c aggregates were depicted on high-power field histology. 2 d after  
DT treatment (19 dpi), the inset of a B220 follicle demonstrates absence of CD11c+ DCs. 1 wk after depletion of CD11c+ DCs, dense aggregates could not be 
detected. (D) Histogram depicts numbers of counted iBALT per low-power field. Bars represent mean values. Three high-power fields were counted per lung 
of at least five animals per group. Error bars indicate SEM. *, P < 0.05. Data are representative of at least two independent experiments.JEM VOL. 206, October 26, 2009  2343
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veolar lavage fluid (BALf) were measured. Although the level 
of class switch–independent IgM remained unaffected by DT 
treatment, IgA levels were readily decreased (Fig. 3 D). The 
presence of preserved IgM responses again argues against di-
rect toxic effects of DT on B cells in CD11cDTR Tg mice, 
as mainly IgM-secreting plasmablasts are sensitive to DT 
treatment (Hebel et al., 2006). Together, the depletion of 
CD11c+ DCs pointed out the importance of iBALT struc-
tures for the local production of antibodies that rely on GCs 
for Ig class switching.
Major contribution of iBALT to systemic humoral immunity
The contribution of iBALT plasma cells to systemic hu-
moral immunity has not been studied in great detail. Serum 
to identify NP-specific B cells (Fig. S2, B and C). Double 
staining for NP specificity with the plasma cell marker CD138 
confirmed that the majority of NP-specific cells within 
iBALT were plasma cells (Fig. S2 D). Strikingly, after local 
depletion of DCs by DT treatment at 17 dpi, these NP-
specific plasma cells could no longer be detected on histology 
24 dpi (Fig. 3 B). This indicated that besides an abrogation of 
iBALT aggregates, depletion of DCs seriously affected local 
immunity. To quantify these changes, multicolor flow cytom-
etry was performed on dispersed lung cells taken 1 wk after 
DC depletion. The number of total B220+CD19+ B cells (not 
depicted) and the number of B220+CD19+ IgMIgDCD95+ 
PNA-positive GC B lymphocytes were significantly de-
creased (Fig. 3 C). Furthermore, local Ig levels in bronchoal-
Figure 3.  Local humoral immunity is affected by DC depletion. (A) Local class switching in the lung is demonstrated on consecutive slides of lung 
tissue at 24 dpi that show IgD, IgG, and IgA in the proximity of GL-7 positive GCs. Bars, 100 µm. (B) Depletion of DCs affected presence of NP-specific 
plasma cells. Bars, 100 µm. (C) Histogram represents the decreased number of B220+CD19+IgMIgDPNA+ cells per 100.000 lung cells 1 wk after DC de-
pletion (DT). (D) Levels of IgM and IgA measured in BALf of mice 1 wk after DC depletion. Bars represent mean values with error bars indicating SEM.  
All results in this figure represent results of at least five mice per group, and similar results were obtained from at least three separate experiments.  
*, P < 0.05; **, P < 0.005; ***, P < 0.001.2344 DCS ARE REQUIRED FOR iBALT MAINTENANCE | GeurtsvanKessel et al.
Fig. 4 B), CD19+CD138+ NP-specific plasma cell numbers 
in BM were found to be significantly decreased. These data 
suggest that even 17 dpi, the formation of a pool of long-
lived plasma cells in the BM depends on continued input of 
B cells that have undergone class switching in the local TLO 
of the lung. Because we found that DC depletion leaves the 
differentiation of NP-specific plasma cells in lung draining 
LNs intact (Fig. S1, B and C), we conclude that iBALT con-
tributes significantly to systemic humoral immunity. Another 
possibility was that lung DCs provided a niche for the survival   
hemagglutinin (HA)-inhibiting antibodies, the gold standard 
correlate of protective systemic immunity to influenza, were 
determined at 24 dpi, 1 wk after DCs and iBALT had been 
abolished by DT treatment. Surprisingly, the local depletion 
of DCs and iBALT led to significantly decreased HA-specific 
antibodies in serum (Fig. 4 A). Although serum virus-specific 
antibodies may derive from plasma cell production locally in 
the lung or draining LNs, an important source of serum anti-
bodies  are  long-lived  BM  plasma  cells  (Radbruch  et  al., 
2006). 1 wk after lung DC depletion by DT treatment (24 dpi; 
Figure 4.  Abrogation of iBALT affected systemic humoral responses. (A) HA inhibition titers measured in serum, indicating the titer of HA-specific 
antibodies. Mice were treated with DT at 17 dpi and serum was obtained at 24 dpi. Data are representative of three independent experiments with five 
mice prr group. Bars indicate mean values with error bars indicating SEM. (B) Number of CD11bCD138+CD95+NP+ plasma cells in BM per 100.000 BM 
cells. All results in this figure represent results of at least four mice per group, and similar results were obtained from at least three separate experiments. 
Horizontal bars indicate the mean value. (C) Secondary homologous influenza virus infection 2 wk after DC depletion (DT) or PBS. 4 d after secondary 
challenge, IgA in BALf was measured (right plot) and 8 d after secondary challenge, HA-inhibiting serum titers were measured (left plot). Bars represent 
mean values with error bars indicating SEM. All results in this figure represent results of at least five mice per group and similar results were obtained 
from at least two separate experiments. *, P < 0.05; ***, P < 0.001; ns, not significant.JEM VOL. 206, October 26, 2009  2345
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DCs from digested lung tissue at various dpi (4, 10, and 17 dpi). 
Importantly, at 17 dpi mRNA expression levels of CXCL12, 
CXCL13, CCL19, and CCL21, as well as the instructive sig-
nal LT, were increased in DCs when compared with those 
at 4 and 10 dpi (Fig. 5 A). We next compared whole lung 
RNA levels of these factors in uninfected mice and influ-
enza-infected mice at 17 dpi as well as 1 d after DT treat-
ment. Only the instructive LT signal was reduced 1 d after 
lung DT treatment in CD11c-DTR Tg mice, whereas levels 
of CXCL13 and CCL21 were unaltered (Fig. 5 B). As at this 
time point, GCs and B cells were not yet affected (Fig. 2 C) 
and so the decrease in LT could not be appointed to a loss 
of B cells. The residual LT signal in DT-treated mice was 
most likely derived from B cells that still formed aggregates at 
this time point (Endres et al., 1999). The fact that homeo-
static chemokines were intact in whole lungs of DC-depleted 
mice (but still increased compared with uninfected lungs) 
suggests that stromal cells were the predominant source of 
these factors, as has been shown previously (Rangel-Moreno 
et al., 2007).
As DC depletion led to a loss of preexisting iBALT and 
was a prominent source of LT, we next addressed the func-
tional role of LT receptor signaling in iBALT maintenance. 
Blocking experiments using LTR-Fc given at 17 dpi (Fig. 5 C) 
led to dissolution of splenic GL-7+ GC reactions, validating 
the efficiency of depletion (Rooney et al., 2000). Like DC 
depletion (Fig. 2), LTR-Fc treatment strongly reduced 
iBALT structures on histology (Fig. 5 C) and the number of 
GL-7+ GC B cells when measured by flow cytometry (Fig. 5 C) 
at 24 dpi. On total lung RNA, LTR-Fc treatment led to a 
strong reduction in CXCL13 levels at 24 dpi, a time point 
when iBALT structures had disappeared (Fig. 5 D). CCL21 
expression however, was not affected by LTR-Fc treatment 
and still increased when compared with naive lungs. As CCL21 
is mainly known as a chemoattractant for T cells, a staining 
for T cells was performed in mice treated with LTR-Fc. 
Although increased T cell numbers were found at 24 dpi in 
the lungs of LTR-Fc–treated infected mice compared with 
uninfected mice, these cells failed to form the dense clusters 
seen in isotype-treated infected animals (Fig. S4). A similar 
effect was seen by depleting DCs in CD11c-DTR mice.
Adoptive transfer of DCs induces iBALT
As a final experiment, we questioned whether adoptive trans-
fer of CD11b+ DCs would also be sufficient to induce iBALT. 
Therefore, GM-CSF–cultured BM DCs, which are an in vitro 
equivalent of in vivo inflammatory type CD11b+ DCs, were 
administered 5× i.t. to naive mice, each with 2-wk intervals. 
2 d after the last DC injection, lungs were immunohisto-
chemically stained and examined for the presence of iBALT. 
Besides B220+ B cell aggregates containing CD11c+ DCs 
(Fig. 5 E), GCs containing GL-7–positive GC B cells were 
found, with some IgM or IgG antibody-secreting plasma 
cells. These findings indicate that DCs may well exert their 
effects on TLO neogenesis directly. However, because we 
have previously shown that adoptive transfer of DCs to the 
of plasma cells in the lung, which subsequently migrated to 
the BM. In support of this hypothesis, we found significant 
production of the B cell survival factors BAFF and APRIL by 
CD11b+CD11c+ DCs sorted from the lungs of influenza-
infected mice but not mock-infected mice (unpublished data). 
As the DT toxin was given locally to the lungs, we can ex-
clude that the reduction in BM plasma cells was caused by 
reduction in BM resident DCs, providing a niche for plasma 
cell survival (Sapoznikov et al., 2008).
To study the biological significance of the decrease in 
lung and/or BM plasma cells, we reinfected mice with the 
homologous virus, causing no systemic illness (unpublished 
data). Mice were infected at day 0 and a second time at day 31. 
Although reinfection did not cause clinical illness, it strongly 
boosted serum HA-inhibiting titers and local IgA responses 
in the BAL fluid when compared with primo-infected mice. 
However, when iBALT structures were affected by DC de-
pletion intermittently at 17 dpi, reinfection led to lower titers 
of these antibodies. However, reinfection in DC-depleted 
mice still elicited stronger humoral immunity when com-
pared with primary infected mice. This was most likely a re-
sult of the fact that DC depletion did not fully reduce the 
pool of long-lived plasma cells in the BM down to the level 
of noninfected mice (Fig. 4 B), nor did it fully abolish local 
IgA responses (Fig. 3 D).
After viral clearance, lung CD11b+ DCs no longer present 
viral antigen yet express homeostatic chemokines
Collectively, our data demonstrated a crucial role for DCs in 
the maintenance of iBALT structures long after virus had been 
cleared from the lungs. This could be a result of ongoing 
presentation of viral antigen by DCs to nearby CD4+ T cells 
(Fig. 1), which subsequently help in organizing the iBALT 
structure and local Ig class switching, as has already been sug-
gested for other TLOs (Marinkovic et al., 2006). However, 
this scenario is less likely, as we studied antigen presentation 
of viral proteins by CD11b+ DCs at various dpi and found 
no evidence of antigen presentation to CD4 T cells beyond   
4 dpi (Fig. S3).
Previous studies in influenza models indicated that ho-
meostatic chemokines (CCL19, CCL21, and CXCL13) are 
mainly produced by stromal cells during iBALT formation 
(Rangel-Moreno et al., 2007). Stromal cells are instructed by 
a lymphotoxin-12 (LT)–positive cell for this chemokine 
production. However, studies of the formation of other 
TLOs have shown that CD11c+Ly6Clo monocytic precursors 
to DCs can also be a source of these chemokines and might 
also provide the LT to instruct stromal cells (Gräbner   
et al., 2009). These chemokines, as well as LT, are thought 
to control both SLO and TLO development by recruiting B 
cells and retaining plasma cells (CXCL12 and CXCL13) and 
by attracting T cells (CCL19 and CCL21; Luther et al., 2002; 
Rangel-Moreno et al., 2007; Gräbner et al., 2009).
To help explain our observations, we studied the expres-
sion levels of LT and homeostatic chemokines in DCs 
during the maintenance of iBALT. We sorted CD11c+CD11b+ 2346 DCS ARE REQUIRED FOR iBALT MAINTENANCE | GeurtsvanKessel et al.
Figure 5.  DCs are capable of maintaining iBALT as a result of chemokine expression. (A) Relative expression of lymphotoxin-, CXCL12, CXCL13, 
CCL19, and CCL21 on sorted CD11b+ DCs obtained from pooled lung tissues of 10 infected mice at various dpi. Bars indicate relative expression. (B) Rela-
tive expression of lymphotoxin-, CXCL13, and CCL21 on total lung RNA of naive mice and with or without DT treatment. Bars represent mean values of 
five mice per group with error bars indicating SEM. *, P < 0.05; ns, not significant. (C) Mice infected at day 0 were treated with LTR-Fc or an isotype at JEM VOL. 206, October 26, 2009  2347
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CD11chi cells were depleted in CD11c-DTR x C57BL/6 Tg mice by i.t. 
injection of 50 ng DT, a dose previously determined by titration. All experi-
ments were approved by an independent animal ethics committee of Eras-
mus MC Medical Center (Rotterdam, Netherlands).
Influenza  virus  infection.  Mice  were  intranasally  infected  with  105 
TCID50 H3N2 influenza virus X-31 (Medical Research Council) diluted in 
50 µl PBS. For antigen presentation assays of lung DCs, mice were infected 
with 105 X-31 influenza virus encoding OVA323-339 MHC II epitope in HA 
of  the  virus  (Thomas  et  al.,  2006).  The  OVA  virus  was  provided  by   
R. Webby (St. Jude Children’s Hospital, Memphis, TN). In some experiments, 
mice were treated at 17 dpi with 200 µg/mouse LTR-Fc (provided by   
C.F. Ware, La Jolla Institute for Allergy and Immunology, San Diego, CA).
Histology. Lungs were inflated with OCT, snap frozen in liquid nitrogen, 
and stored at 80°C. Frozen sections were fixed in acetone and endogenic 
peroxidase was blocked before immunohistochemical staining. Immunohis-
tochemical double staining was performed for B220 (RA3-6B2; BD) and 
CD11c (N418; eBioscience), CD8 (KT-15; AbD Serotec) and CD4 (RM4-5; 
eBioscience), GL7 (BD) and IgD (eBioscience), IgG (A85-1; BD) and 
PNA  (L-6135; Sigma-Aldrich), IgA (02262D; BD) and PNA, and IgM   
(II-41; BD) and KT3 (supernatant). FDC (M2; BD) was single stained. For 
detection of NP-positive cells, slides were incubated with recombinant NP 
(Voeten et al., 1998) before FITC-labeled anti-NP staining. Slides were 
digitized on a Digital Zoom Microscope (Hamamatsu). All depicted pictures 
are representative of at least five mice per group. Quantification of iBALT 
was performed by counts of the number of GL-7–positive structures per 
high-power field. Three high-power fields were counted per lung of at least 
five mice per group.
Detection of antibodies in serum and BALf. For detection of HA-specific 
antibodies in serum, samples were treated with cholera filtrate and heat inacti-
vated at 56°C. The serum samples were tested for the presence of anti-HA an-
tibodies. For this purpose, an HA inhibition assay was used according to a 
standard protocol of 1% turkey erythrocytes and 4 HA units of H3N2 influenza 
virus (Masurel et al., 1981) in 96-wells plates (Greiner Bio-One). ELISA was 
performed on BALf for detection of IgA (BD) and IgM (SouthernBiotech).
Adoptive transfer of GM-CSF–cultured DCs. BM cells were cultured 
for 9 d in DC culture medium (DC-TCM; RPMI 1640 containing Gluta-
MAX-I [Invitrogen] supplemented with 5% [vol/vol] FCS [Sigma-Aldrich], 
50 µM 2-mercaptoethanol [Sigma-Aldrich], 50 µg/ml gentamicin [Invitro-
gen], and 20 ng/ml of recombinant mouse GM-CSF [gift from K. Thielemans, 
Vrije Universiteit Brussel, Brussels, Belgium]). Mice received five i.t. injec-
tions of 106 DCs, each with a 2-wk interval.
Flow cytometry and cell sorting. To check the depletion of cell subsets 
after treatment with DT and analyze tissues after depletion, single cell sus-
pensions of lung and BM were prepared as described previously (de Heer   
et al., 2004). Extracellular staining for DCs was done by staining with 120G8 
FITC (provided by C. Asselin-Paturel, Schering-Plough Laboratory for 
Immunological Research, Dardilly, France), CD11b PE, MHCII PECy5, B220 
lungs causes airway inflammation (Lambrecht et al., 2000a) it 
is also conceivable these effects on TLO neogenesis are in-
duced via chronic inflammation. However, in a chronic lung 
inflammation model using chronic OVA aerosol exposure 
for equally long time periods, we failed to detect significant 
iBALT structures (unpublished data).
Concluding remarks
Previous work on the role of iBALT structures in mediating 
immunity to influenza have all used genetic targeting strategies 
that led to deficiencies of SLO in addition to TLO, potentially 
overemphasizing the contribution of iBALT to antiviral im-
munity (Moyron-Quiroz et al., 2004). Using the induced de-
pletion of DCs to eliminate iBALT, but not SLO, we were 
able to demonstrate a clear role for these structures in both lo-
cal and systemic humoral immunity to influenza virus.
A big question that remains in the field of ectopic lym-
phoid tissue development is the precise character of the LT+ 
lymphoid tissue inducer cells that provide the initial trigger 
for TLO development to stromal organizer cells (Marinkovic 
et al., 2006). As we have studied the maintenance of TLO in 
the lung, our paper does not answer this question but pro-
vides clear evidence that DCs play a crucial role in the orga-
nization and maintenance of established TLO. We suggest a 
model by which the CD11b+ DC maintains TLO by provid-
ing a continued source of LT that is necessary for maintain-
ing high levels CXCL13 and retention of B cells inside the 
TLO structure. Although DCs can be a direct source of ho-
meostatic chemokines, most likely stromal cells are quantita-
tively more important (Rangel-Moreno et al., 2007). However, 
in the induced absence of DCs or under conditions of LTR 
blockade, continued production of homeostatic chemokines 
by stromal cells is not sufficient for maintaining the iBALT 
structure. One possibility that remains to be elucidated is that 
DCs are crucial for the correct positioning of stromal-derived 
homeostatic chemokines. By binding and displaying stromal-
derived chemokines on their surface, DCs could retain   
T cells and B cells in dense clusters, which are necessary for 
GC reactions and immunoglobulin class switching.
MATERIALS AND METHODS
Mice. C57BL/6 mice (6–8 wk) were purchased from Harlan Laboratories. 
The generation and screening of CD11c-DTR Tg mice has been reported 
previously (Jung et al., 2002). Male BALB/c background CD11c-DTR Tg 
(H2-Dd) mice were crossed with C57BL/6 (H2-Db) to obtain F1 progeny. 
17 dpi and analyzed 24 dpi. The left histogram represents GL-7–positive cells in lung tissue measured by flow cytometry, with bars representing mean 
values of five mice per group and error bars indicating SEM. *, P < 0.05. Histology of spleen (top) and lung (bottom) demonstrate high-power field images 
of GL7-IgD aggregates after treatment with LTR-Fc or an isotype, representative of at least five mice per group. Bars, 1,000 µm. The right histogram 
demonstrates numbers of counted iBALT/high-power field. Bars represent mean values of three high-power fields counted per lung of at least five ani-
mals per group. Error bars indicate SEM. **, P < 0.01. (D) Relative expression of lymphotoxin-, CXCL13, and CCL21 on total lung RNA of naive mice and  
1 wk after LTR-Fc or isotype treatment. Bars represent mean values of five mice per group with error bars indicating SEM. *, P < 0.05; **, P < 0.005; ns, 
not significant. (E) Repetitive adoptive transfer of cultured GM-CSF DCs induced iBALT. DCs were grown from BM and injected five times with 2-wk inter-
vals as a control PBS was injected. Consecutive histological slides show presence of iBALT aggregates. Bars, 100 µm. The histogram demonstrates numbers 
of counted iBALT per high-power field. Bars represent mean values of three low-power fields counted per lung of at least five animals per group. Error 
bars indicate SEM. *, P < 0.05. All experiments in this figure have been independently performed twice with at least five mice per group.
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